Gemcabene 900 mg

DRUG5 trials

Sponsors

NeuroBo Pharmaceuticals Inc.

Conditions

HypercholesteremiaHypercholesterolemiaHypertriglyceridemiaInsulin Sensitivity

Phase 1

Effect of Gemcabene on the Pharmacokinetics of Simvastatin in Healthy Volunteers

CompletedNCT02587390

NeuroBo Pharmaceuticals Inc.Hypercholesterolemia

Start: 2000-05-31End: 2000-07-31Updated: 2020-04-09

Effect of Gemcabene on the Pharmacokinetics of Atorvastatin in Healthy Volunteers

CompletedNCT02587416

NeuroBo Pharmaceuticals Inc.Hypercholesteremia

Start: 2002-11-30End: 2002-12-31Updated: 2020-04-09

Pharmacokinetics and Pharmacodynamics Study of Gemcabene in Healthy Volunteers

CompletedNCT02587364

NeuroBo Pharmaceuticals Inc.Hypercholesterolemia

Start: 1999-04-30End: 1999-09-30Updated: 2020-04-09

Phase 2

Efficacy and Safety of Gemcabene in Patients With Low HDL-C and Either Normal or Elevated Triglycerides

CompletedNCT02585869

NeuroBo Pharmaceuticals Inc.Hypercholesterolemia, Hypertriglyceridemia

Start: 1999-12-31End: 2001-06-30Updated: 2020-04-09

The Effect of Gemcabene on Insulin Sensitivity in Nondiabetic Subjects

CompletedNCT02586168

NeuroBo Pharmaceuticals Inc.Insulin Sensitivity

Start: 2001-07-31End: 2001-10-31Updated: 2020-04-09